Report Highlights
The global market HCAI Control should grow from $24.0 billion in 2021 to $36.2 billion by 2026, at compound annual growth rate (CAGR) of 8.6% for the period of 2021-2026.
Report Includes
- 72 tables
- An updated review of the global healthcare-acquired infection (HCAI)-control market
- Analyses of the global market trends, with data from 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
- Highlights of select antimicrobials drugs and environment sterilization/disinfection products currently used or under development for treatment of healthcare-associated infections
- Market outlook and forecast trends of pharmaceutical treatment (antimicrobials and vaccines), environment treatment (disinfectants, sterilization systems etc.) and provisions in medical devices (catheters, patient ventilation devices, sterile intravenous [IV] filters) that prevent the occurrence of nosocomial infections
- Estimation of the market size and revenue forecasts for HCAI-control market, and corresponding market share analysis by key market segments — technology type, application, and geography
- Discussion of the key market dynamics, industry structure, regulatory approval, market deterrents, unmet needs and other factors driving opportunities in microbiology research
- A look at the pipeline products for antimicrobial resistance (AMR), hospital surveillance methods and tools used to control HCAI infections
- Review of the U.S. patent grants for innovations in infectious diseases control and viral infections
- Profile descriptions of the leading industry players including 3M, Merck, Novartis’, Pfizer, Roche, and Sanofi
Report Scope
The report focuses on select drugs (antimicrobials), environment treatment (disinfectants, sterilization systems etc.) and provisions in medical devices (e.g., catheters, patient ventilation devices, sterile IV filters) that prevent the occurrence of nosocomial infections.
Within each type of treatment, regional analyses will focus on the Americas (i.e., Canada, the U.S., Mexico, Central America and South America), EMRA (i.e., Europe, the Middle East, Russia and Africa) and Asia-Pacific (i.e., Japan, China, India, other Western Pacific countries such as Australia and New Zealand, and other Southeast Asian countries).
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Siemens: 360° Company Analysis (IFT322A)
- Thermo Fisher Scientific Inc.: 360° Company Analysis (HLC309A)
- Needle-Free Devices: Technologies and Global Markets (HLC178C)
- Koninklijke Philips N.V.: 360° Company Analysis (HLC308A)
- Global High Purity Quartz Market (CHM191A)
Related Reports
Global Breathing Circuits Market
The global breathing circuits market reached $1.2 billion in 2022, should reach $1.3 billion by 2023 and $1.6 billion by 2028 with a compound annual growth rate (CAGR) of 5.1% during the forecast period of 2023-2028.
Antibiotics: Technologies and Global Markets
The global antibiotics market reached $40.4 billion in 2022 and should reach $49.6 billion by 2027, with a compound annual growth rate (CAGR) of 4.2% during the forecast period of 2022-2027.
Ultraviolet (UV) Disinfection Equipment: Major Applications and Global Markets
The global ultraviolet (UV) disinfection equipment market should reach $10.1 billion by 2027 from $4.9 billion in 2022 at a compound annual growth rate (CAGR) of 15.4% for the forecast period of 2022 to 2027.
Global Markets for Sterilization Technologies
The global sterilization technologies market reached $8 billion in 2022 and should reach $12.3 billion by 2027, with a compound annual growth rate (CAGR) of 8.8% during the forecast period of 2022-2027.
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Thermo Fisher Scientific Inc.: 360° Company Analysis
This report provides a comprehensive analysis of Thermo Fisher Scientific Inc., covering key details such as key milestones/history, product offerings, technologies, major applications and end-user industries it serves.
Needle-Free Devices: Technologies and Global Markets
The global market for needle-free devices was valued at $15.5 billion in 2024 and is estimated to increase from $17.0 billion in 2025 to reach $27.7 billion by 2030, at a compound annual growth rate (CAGR) of 10.2% from 2025 through 2030.
Koninklijke Philips N.V.: 360° Company Analysis
The report discusses a 360° analysis of Koninklijke Philips N.V. It covers various aspects of Koninklijke Philips N.V., including products, business segments, history, distributors, and financial and strategic development.
Global Thyroid Gland Disorders: Diagnostics and Treatment Market
The global market for diagnostics and treatment of thyroid gland disorders was valued at $15.5 billion in 2024 and is estimated to increase from $16.3 billion in 2025 to reach $21.0 billion by 2030, at a compound annual growth rate (CAGR) of 5.2% from 2025 through 2030.
Global Outpatient Clinics Market
The global outpatient clinics market is expected to grow from $4.4 trillion in 2024 and is projected to reach $6.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 7.6% during the forecast period of 2024 to 2029.
Top Trending Reports
Next-Generation Advanced Batteries: Global Markets
The global market for next-generation advanced batteries is estimated to grow from $1.5 billion in 2024 to reach $5.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 28.5% from 2024 through 2029.
Global Pharmaceutical Drugs Industry: Competitive Landscape 2023
This report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.
Global Markets and Manufacturing Technologies for Protein Drugs
The global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.
Biologic Therapeutic Drugs: Technologies and Global Markets
The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.
Global Markets for Emerging Medical Device Technologies
The global market for emerging medical devices is estimated to increase from $136.6 billion in 2024 to reach $223.9 billion by 2029, at a compound annual growth rate (CAGR) of 10.4% from 2024 through 2029.
Report Highlights
The global market for healthcare-acquired infection (HCAI) control should grow from $18.9 billion in 2018 to $24.7 billion by 2023 at a compound annual growth rate (CAGR) of 5.4% from 2018 through 2023.
Report Includes
- 42 data tables and 32 additional tables
- Industry analysis of the global healthcare-acquired infection (HCAI) control market
- Detailed overview and trend analysis of pharmaceutical treatment (antimicrobials and vaccines), environment treatment (disinfectants, sterilization systems etc.) and provisions in medical devices (catheters, patient ventilation devices, sterile intravenous [IV] filters) that prevent these infections
- Analyses of global market trends with data from 2017, estimates for 2018 and projections of compound annual growth rates (CAGRs) through 2023
- Emphasis on selected devices, pharmaceuticals and environmental products currently employed or under development for treatment of viral, bacterial and fungal infections
- Analysis of antimicrobial resistance and more specifically antibiotic resistance as a cause for these infections
- A look at the hospital surveillance methods and tools currently being used to prevent these infections
- Regional analysis of the market covering Americas (i.e. Canada, the U.S., Mexico, Central America and South America), EMRA (i.e. Europe, the Middle East, Russia and Africa); and Asia-Pacific (i.e. Japan, China, India, other Western Pacific countries such as Australia and New Zealand and other Southeast Asian countries)
- Information on key patents and newer research developments in sterilization systems and devices
- Examination of vendor landscape and profiles of key players in the HCAI market, including Novartis, Pfizer, Roche, 3M Healthcare and Sanofi Pasteur
Report Highlights
The global market for selected healthcare-acquired infection (HAI) treatments was valued at nearly $15.2 billion in 2014. This market is expected to increase from nearly $17.1 billion in 2015 to $23 billion by 2020, with a compound annual growth rate (CAGR) of 6.1% from 2015 to 2020.
Report Includes
- Forecasts of the markets for healthcare-acquired infection (HAI) devices, pharmaceuticals, and therapies by treatment segment and treatment type, including supporting analyses for projections
- Analyses of global market trends, with data from 2014, estimates for 2015, and projections of CAGRs through 2020
- Valuable tools for anyone assessing the HAI market and attempting to devise a strategy to successfully compete in the industry
- Information needed to understand the current market and to address the emerging market.
Report Highlights
The global market for selected HAI treatments was nearly $12.1. billion in 2012. The market is expected to reach $14.0 billion in 2013 and nearly $20.8 billion in 2018 with a compound annual growth rate (CAGR) of 8.2%.
Report Includes
- Forecasts of the markets for healthcare-acquired infection (HAI) devices, pharmaceuticals, and therapies by treatment segment and treatment type, including supporting analyses for projections
- Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018
- Valuable tools for anyone assessing the HAI market and attempting to devise a strategy to successfully compete in the industry
- Background on the structure of the HAI market and the opportunities available as well as the chief challenges it faces
- Information needed to understand the current market and to address the emerging market
- Comprehensive company profiles of key players in the market.
Report Highlights
The global market for healthcare-acquired infection treatments were nearly $16 billion in year 2010. This market is estimated to be around $18.3 billion in the year 2011 and is forecasted to reach $25.6 billion by 2016 at a CAGR of 7.0% for five year period.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More